《T a b l e4Di a g n o s t i c a c c u r a c y o f PIVKA-II, AFPf o r\n\t\t\t\t\td i f f e r e
本系列图表出处文件名:随高清版一同展现
《Protein induced by vitamin K absence or antagonist-Ⅱ versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis》
A FP:a l p h a-f e t o p r o t e i n;AUC:a r e a u n d e r t h e ROCc u r v e;DOR:d i a g n o s t i c o d d s r a t i o;PIVKA-II:p r o t e i n i n d u c e d b y v i t a m i n Ka b s e n c e o r a n t a g o n i s t-II.
Serum markers for early diagnosis of patients with high risk of HCC offer an opportunity to decrease HCC mortality and reduce medical costs.In this meta-analysis,the greater AUC of PIVKA-II(0.856)over AFP(0.770)proves that PIVKA-II is better than AFP for detecting HCC.Furthermore,while the sensitivity of PIVKA-II was comparable to that of AFP in detecting small HCC(<3 cm),both the specificity and AUC of PIVKA-II were significantly higher than those of AFP.In subgroup analysis of ethnic groups,The AUC of PIVKA-II was significantly higher than that of AFP in detecting HCC among American,European and African patients.Although AFP performed better in African patients in specificity,higher sensitivity and AUC were found in PIVKA-II.In subgroup analysis of etiology,PIVKA-II performed better than AFP in detecting HBV-related,HCV-related or mixed-etiology HCC.Based on the results of subgroup analysis,we conclude that the diagnostic performance of PIVKA-II is worthy of further promotion in clinical practice.Please note that caution must be taken when interpreting the results of subgroup analyses because the number of studies was limited in this meta-analysis.Only one study was available for African patients and two studies for HCV-related HCC.The exclusion criteria in our study eliminated many Japanese studies in which HCV was the main cause of HCC,which affected the statistical power in the analysis of HCV-related HCC.In short,more studies are needed to allow more assertive conclusion to be made.
图表编号 | XD0020455900 严禁用于非法目的 |
---|---|
绘制时间 | 2018.12.15 |
作者 | Hao Xing、Yi-Jie Zheng、Jun Han、Han Zhang、Zhen-Li Li、Wan-Yee Lau、Feng Shen、Tian Yang |
绘制单位 | Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University、Medical Scientific Affairs, Abbott Diagnostics、Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University、Department of He |
更多格式 | 高清、无水印(增值服务) |
查看“T a b l e4Di a g n o s t i c a c c u r a c y o f PIVKA-II, AFPf o r\n\t\t\t\t\td i f f e r e n t t y p e s o f HCC”的人还看了
- 表2龙陵县珍稀濒危药用植物分布情况Ta b l e2Di s t r i b u t i o n o f r a r e a n d e n d a n g e r e d m e d i c i n a l p l a n t s i n
- 表3果实发育期强酸味成分皮尔逊相关系数分析表 (n=8) Ta b l e3Th e Pe a r s o n’s c o r r e l a t i o n a n a l y s i s t a b l e o f s t r o n
- T a b l e3Pe r c e n t a g e o f m o t i l e s p e r m a n d s p e r m s w i m m i n g a b i l i t y, a n d s p e r m m